JAVLOR Association Study in CDDP-unfit Patients With Advanced Transitional Cell Carcinoma: Gemcitabine Versus Carboplatin
Clinical trial NCT01599013 · COMPLETED
Trial details
- NCT number
- NCT01599013
- Sponsor
- Pierre Fabre Medicament
- Status
- COMPLETED
- Phase
- Phase 2
- Study type
- INTERVENTIONAL
- Start date
- 2011-02-01
- Primary completion
- 2013-10-01
- Enrollment
- 69
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.